Search Results - "Wiklund F"

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.

Authors: Lenner, P. Wiklund, F. Emdin, S.O. et al.

Source: British Journal of Cancer. 2/15/99, Vol. 79 Issue 5/6, p927. 6p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Detection of adeno-associated virus type 2 genome in cervical carcinoma.

Authors: Zheng, B. Y. Li, X. D. Wiklund, F. et al.

Source: British Journal of Cancer. 6/19/2006, Vol. 94 Issue 12, p1913-1917. 5p. 3 Charts.

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.

Authors: Lindmark, F. Zheng, S. L. Wiklund, F. et al.

Source: British Journal of Cancer. 8/22/2005, Vol. 93 Issue 4, p493-497. 5p.

POD-09.03: Endovesical epirubicin and interferon α 2b is comparable to BCG as adjuvant treatment for T1 tumours with or without CIS

Authors: Duchek, M. Wiklund, F. Jahnson, S. et al.

Source: Urology. Sep2007 Supplement, Vol. 70 Issue 3, p28-28. 1p.

Cumulative association of five genetic variants with prostate cancer.

Authors: Zheng SL Sun J Wiklund F et al.

Source: New England Journal of Medicine. 2/28/2008, Vol. 358 Issue 9, p910-919. 10p.

URL: 31162880

Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.

Authors: Cederquist, K. Emanuelsson, M. Wiklund, F. et al.

Source: Clinical Genetics. Dec2005, Vol. 68 Issue 6, p533-541. 9p. 2 Diagrams, 1 Chart, 2 Graphs.

Mendelian randomisation analysis provides no evidence for a relationship between adult height and testicular cancer risk.

Authors: Levy, M. Hall, D. Sud, A. et al.

Source: Andrology. Sep2017, Vol. 5 Issue 5, p914-922. 9p.

N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.

Authors: Whitaker, H C Shiong, L L Kay, J D et al.

Source: Oncogene. 11/6/2014, Vol. 33 Issue 45, p5274-5287. 14p. 6 Charts, 5 Graphs.

Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.

Authors: Juliusson, G. Billström, R. Gruber, A. et al.

Source: Leukemia (08876924). Jan2006, Vol. 20 Issue 1, p42-47. 6p. 1 Chart, 4 Graphs.

No link between viral findings in the prostate and subsequent cancer development.

Authors: Bergh, J. Marklund, I. Gustavsson, C. et al.

Source: British Journal of Cancer. 1/15/2007, Vol. 96 Issue 1, p137-139. 3p. 1 Chart.

A0725 - Stockholm3 validation in a multi-Ethnic cohort for ProsTAte cancer (SEPTA) detection: A multicentered, prospective trial.

Authors: Vigneswaran, H.T. Eklund, M. Discacciati, A. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS1692-S1693. 2p.

Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor.

Authors: Andreassen, K.E. Kristiansen, W. Karlsson, R. et al.

Source: Human Reproduction. Jul2013, Vol. 28 Issue 7, p1995-2002. 8p. 2 Charts, 1 Graph.

Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.

Authors: Kristiansen W Andreassen KE Karlsson R et al.

Source: Human Reproduction. May2012, Vol. 27 Issue 5, p1525-1535. 11p.

Familial concordance in cancer survival: a Swedish population-based study.

Authors: Lindström LS Hall P Hartman M et al.

Source: Lancet Oncology. Nov2007, Vol. 8 Issue 11, p1001-1006. 6p.

Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3

Authors: Widmark, A. Fosså, S.D. Lundmo, P. et al.

Source: Urology. Jan2003, Vol. 61 Issue 1, p145-151. 7p.

Prostate cancer screening in men aged 50 to 69 years (STHLM3): A prospective population-based diagnostic study. Grönberg H, Adolfsson J, Aly M, Nordström T, Wiklund P, Brandberg Y, Thompson J, Wiklund F, Lindberg J, Clements M, Egevad L, Eklund M.Lancet Oncol. 2015 Dec;16(16):1667-76. [Epub 2015 Nov 10]. doi: 10.1016/S1470-2045(15)00361-7.

Authors: Scott, Eggener Adolfsson, J Aly, M et al.

Source: Urologic Oncology. Mar2017, Vol. 35 Issue 3, p120-120. 1p.

86 The STHLM3 model improves prostate cancer testing in men 50-69 years - further health economic and clinic evaluation.

Authors: Grönberg, H. Adolfsson, J. Aly, M. et al.

Source: European Urology Supplements. Mar2016, Vol. 15 Issue 3, pe86-e86. 1p.

860 STHLM3 – a prospective diagnostic study of prostate cancer.

Authors: Gronberg, H. Eklund, M. Clements, M. et al.

Source: European Urology Supplements. Apr2014, Vol. 13 Issue 1, pe860-e860. 1p.